|
|
Volumn 103, Issue 2, 2011, Pages 87-89
|
|
How do you tell whether a breast cancer is HER2 positive? Ongoing studies keep debate in high gear.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DNA;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERBB2 PROTEIN, HUMAN;
MONOCLONAL ANTIBODY;
TRASTUZUMAB;
TUMOR MARKER;
BREAST TUMOR;
CHEMISTRY;
DRUG APPROVAL;
DRUG EFFECT;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
FOOD AND DRUG ADMINISTRATION;
GENETICS;
HUMAN;
IMMUNOHISTOCHEMISTRY;
NOTE;
PREDICTIVE VALUE;
REPRODUCIBILITY;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
DNA;
DRUG APPROVAL;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
IN SITU HYBRIDIZATION, FLUORESCENCE;
PREDICTIVE VALUE OF TESTS;
RECEPTOR, ERBB-2;
REPRODUCIBILITY OF RESULTS;
TUMOR MARKERS, BIOLOGICAL;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 79952228437
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djq557 Document Type: Note |
|
Times cited : (23)
|
|
References (0)
|
